GPR153
Probable G-protein coupled receptor 153
Also known as: GP153_HUMAN, PGR1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6NV75
- Gene
- GPR153
- Ensembl
- ENSG00000158292
- Chromosome
- 1
- Canonical length
- 609 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes an integral membrane protein that belongs to the Class A rhodopsin superfamily of G protein coupled receptors. The encoded protein is expressed primarily in the central nervous system. A knockdown of the orthologous gene in rat is associated with a significant reduction in food intake and impaired decision making ability. Mutations in this gene are associated with schizophrenia, autism, and other neuropsychiatric disorders. The expression of this gene is activated by the glioma-associated oncogene homolog 1 transcription factor which, in turn, is activated by sonic hedgehog in normal and tumorigenic cells. [provided by RefSeq, Feb 2017]
Canonical amino-acid sequenceUniProt
609 residues, UniProt reviewed canonical sequence.
>Q6NV75|GPR153
1 MSDERRLPGS AVGWLVCGGL SLLANAWGIL SVGAKQKKWK PLEFLLCTLA ATHMLNVAVP
61 IATYSVVQLR RQRPDFEWNE GLCKVFVSTF YTLTLATCFS VTSLSYHRMW MVCWPVNYRL
121 SNAKKQAVHT VMGIWMVSFI LSALPAVGWH DTSERFYTHG CRFIVAEIGL GFGVCFLLLV
181 GGSVAMGVIC TAIALFQTLA VQVGRQADRR AFTVPTIVVE DAQGKRRSSI DGSEPAKTSL
241 QTTGLVTTIV FIYDCLMGFP VLVVSFSSLR ADASAPWMAL CVLWCSVAQA LLLPVFLWAC
301 DRYRADLKAV REKCMALMAN DEESDDETSL EGGISPDLVL ERSLDYGYGG DFVALDRMAK
361 YEISALEGGL PQLYPLRPLQ EDKMQYLQVP PTRRFSHDDA DVWAAVPLPA FLPRWGSGED
421 LAALAHLVLP AGPERRRASL LAFAEDAPPS RARRRSAESL LSLRPSALDS GPRGARDSPP
481 GSPRRRPGPG PRSASASLLP DAFALTAFEC EPQALRRPPG PFPAAPAAPD GADPGEAPTP
541 PSSAQRSPGP RPSAHSHAGS LRPGLSASWG EPGGLRAAGG GGSTSSFLSS PSESSGYATL
601 HSDSLGSASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR153 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 20 nTPM
- amygdala: 13 nTPM
- adipose tissue: 12 nTPM
- cervix: 12 nTPM
- pituitary gland: 11 nTPM
- epididymis: 11 nTPM
Single-cell type
- goblet cells: 110 nCPM
- retinal horizontal cells: 58 nCPM
- ocular epithelial cells: 54 nCPM
- retinal amacrine cells: 53 nCPM
- hepatocytes: 45 nCPM
- lactotrophs: 35 nCPM
Immune cell
- basophil: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- naive CD8 T-cell: 0.2 nTPM
- eosinophil: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- thalamus: 63 nTPM
- amygdala: 41 nTPM
- midbrain: 28 nTPM
- cerebral cortex: 26 nTPM
- hypothalamus: 23 nTPM
- hippocampal formation: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GPR153.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 149 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.67
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR153 as an antibody target. Whether an autoantibody or antibody against GPR153 could matter depends on whether native GPR153 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR153 is annotated at the cell surface, where native GPR153 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR153 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...